Serum prorenin levels are not associated with ocular diseases in non-diabetic subjects.

about

Serum prorenin levels are not associated with ocular diseases in non-diabetic subjects.

Item

http://www.wikidata.org/entity/Q51314073

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Serum prorenin levels are not associated with ocular diseases in non-diabetic subjects.

@en

Serum prorenin levels are not associated with ocular diseases in non-diabetic subjects.

@nl

type

Item

label

Serum prorenin levels are not associated with ocular diseases in non-diabetic subjects.

@en

Serum prorenin levels are not associated with ocular diseases in non-diabetic subjects.

@nl

prefLabel

Serum prorenin levels are not associated with ocular diseases in non-diabetic subjects.

@en

Serum prorenin levels are not associated with ocular diseases in non-diabetic subjects.

@nl

P1476

Serum prorenin levels are not associated with ocular diseases in non-diabetic subjects.

@en

P2093

Akito Shimouchi

http://www.w3.org/2001/XMLSchema#string

Akitoshi Yoshida

http://www.w3.org/2001/XMLSchema#string

Atsushi Takahashi

http://www.w3.org/2001/XMLSchema#string

Eiichi Sato

http://www.w3.org/2001/XMLSchema#string

Harumasa Yokota

http://www.w3.org/2001/XMLSchema#string

Taiji Nagaoka

http://www.w3.org/2001/XMLSchema#string

P2860

Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin

(Pro)renin receptor promotes choroidal neovascularization by activating its signal transduction and tissue renin-angiotensin system.

Serum prorenin levels and diabetic retinopathy in type 2 diabetes: new method to measure serum level of prorenin using antibody activating direct kinetic assay

Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver.

Drug discovery for overcoming chronic kidney disease (CKD): new therapy for CKD by a (pro)renin-receptor-blocking decoy peptide.

Plasma prorenin and renin in anephric patients.

(Pro)renin receptor-mediated signal transduction and tissue renin-angiotensin system contribute to diabetes-induced retinal inflammation.

RILLKKMPSV influences the vasculature, neurons and glia, and (pro)renin receptor expression in the retina.

(Pro)renin receptor is associated with angiogenic activity in proliferative diabetic retinopathy.

Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans.

P304

153-158

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1470320314551442

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267046153

http://www.w3.org/2001/XMLSchema#string

P698

25324425

http://www.w3.org/2001/XMLSchema#string